By Bedfont Scientific Limited Intermedical UK proudly delivers the 3,000th NObreath® FeNO device to the UK market.
|
By Bedfont Scientific Limited coVita™ and Allergy Partners team up to improve asthma care in America
|
By Bedfont Scientific Limited Rbeck Healthtech Private completes registration for the NObreath® FeNO device, helping to improve asthma care across the region.
|
By Bedfont Scientific Limited The NObreath® device enhances access to FeNO diagnostics in Mexico.
|
By Cochrane & Associates, LLC The IAQ Video Network releases another production promoting environmental, health, and safety (EHS) awareness.
|
By KL Krems A study by KL Krems and MedUni Vienna identifies a majority of asthma cases as allergic and opens access to effective, affordable immunotherapy.
|
By EnviroBiotics Partnership with InOvate Technologies Inc. to Expand Market Reach
|
By GAAPP Global Allergy and Airways Patient Platform is excited to announce the appointment of Karen Rance, DNP, CPNP, as our new Chief Medical Officer. Karen is a seasoned medical affairs executive with decades of experience in the allergy and immunology fields.
|
By Cochrane & Associates, LLC The IAQ Video Network releases another educational production about an important environmental, health, and safety (EHS) topic.
|
By GAAPP Patient advocates unite to highlight a common challenge for their community
|
